register now
conference
get brochure
add event to diary
email this to...
contact us

conference details
Investing in Vaccines Day
Monday 20 April 2009
 
Governmental and Philanthropic Funding
 
Corporate Venture Capital - Dividends "Beyond the Bottom Line"
 
Navigating the Venture Path: The Quickest Route to Money
 
Conference Day One
Tuesday 21 April 2009
 
Vaccines: Who's Calling the Shots?
 
Industry Injection - A Role for Pharma
 
Global Health: Making Partnerships Work
 
Conference Day Two
Wednesday 22 April 2009
 
Vaccine R&D: What's Over the Horizon?
 
Redrawing the Vaccine Frontier
 
Taking Aim at Novel Markets
 
Influenza Evolution
 
Regulatory Pathways to Approval
 
Targetting Biodefense Markets
 
Conference Day Three
Thursday 23 April 2009
 
R&D Growth Strategies
 
Vaccine Clinical Trials and Tribulations
 
Production, Manufacture and Capacity
 
HIV Vaccines - Progress and Prospects
 
Cancer Vaccines and Immunotherapy
 
Adjuvants and Delivery Techniques
 
Post Market Evaluation
 
>> See the full programme
>> Register now
 

 

 

 

 
 
Meet the world's key vaccine industry players
The 9th annual World Vaccine Congress Washington is set to be a phenomenal event! Last year saw over 350 attendees from over 200 companies descend upon the Hyatt Regency Crystal City, and this year is sure to be even BIGGER and BETTER!  
For delegates
Last year's event presented an unrivalled list of statistics which we feel are critical to enabling you to make an informed decision on attending the 2009 congress:
  • 380+ attendees
  • 70% buy-side attendance
  • 85% Director / VP / C-level attendance
  • 25+ countries represented
At the World Vaccine Congress Washington 2009 you will be given the opportunity to focus on strategic issues in the vaccine industry, explore ways to further your products and technologies, and make new contacts through several organized networking events.
 
 
Vaccine Industry Excellence Awards
In 2008 we launched the ViE Awards to recognise the efforts, accomplishments, and positive contributions of organisations and individuals in the global vaccine industry. The ViE Awards Ceremony and Gala Dinner was the evening highlight of the conference, and proved to be a popular event. Congratulations to all the winners, and we hope to see you again next year!

» Learn more about the ViE Awards

Topics and sessions to be included in the World Vaccine Congress Washington 2009 agenda include:

  • Investing in vaccines
  • Governmental and philanthropic funding
  • Corporate venture capital - dividends ‘beyond the bottom line’
  • Navigating the venture path: the quickest route to money
  • Vaccines: who's calling the shots?
  • Vaccine industry injection
  • Global health: making partnerships work
  • The golden shot of vaccine R&D
  • Novel vaccine introduction
  • Redrawing the vaccine frontier
  • Regulatory pathways to approval
  • Influenza evolution
  • Targeting biodefense markets
  • Re-energising growth strategies
  • Vaccine licensing and acquisition strategies
  • HIV vaccines – progress and prospects
  • Cancer vaccines and immunotherapy
  • Vaccine clinical trials and tribulations
  • Vaccine manufacture and technology
  • Adjuvants and delivery systems
  • Post-market vaccine evaluation
You can now get a sneak preview of the 2009 agenda. Simply click here to download your copy of the Advanced Notice Agenda!

Our speakers
The World Vaccine Congress Washington 2008 benefitted from an exceptional speaker line-up, featuring the who's who of the vaccine industry.

  • 85% Director / VP / C-level pharmaceutical speakers
  • 90% C-level biotech speakers
  • 85% NEW speakers and NEW content in 2008

This year there will of course be case study updates, and we will strive to introduce fresh content as we continue to keep track of the latest developments.

» Interested in becoming a speaker?
» Reserve your seat now

For sponsors
The World Vaccine Congress Washington 2009 is the perfect environment for you to demonstrate new products, introduce new services or solutions and engage face-to-face with your target audience. Sponsors are world leading service and solution providers, and delegates are decision makers from across the world.

There are limited sponsorship opportunities available for companies who wish to position themselves at the forefront of the vaccine industry. The World Vaccine Congress Washington 2009 is your best chance to do vaccine business globally.

» Find out how you could benefit
» Reserve your seat now

register today
Benefit from an outstanding marketing campaign!
Before, during and after the event!
The World Vaccine Congress Washington 2009 is more than just an event – it is an opportunity to take an important place in a regional, targeted, 24/7 marketing campaign. The earlier you confirm your participation, the more marketing benefits and the greater ROI you will receive.
 
Our sponsors enjoy unparalleled market exposure that culminates in face-to-face meetings with existing customers and new business prospects. We undertake a comprehensive global marketing campaign reaching the highest echelons within your targeted markets.

» Find out more about sponsorship opportunities at WVC Washington 2009
» Looking for an event taking place sooner or in a different part of the world?

 

exhibitors

Sponosor

Sponosor

Sponosor

Sponosor

 

Sponosor

 

Sponsor now

event sponsors
Gold:
› See the full sponsors list

sponsorship opportunities
Grow your business - sponsorship really works!
  • Get cost effective marketing exposure and branding to your target audience, culminating in face-to-face meetings with your top prospects
  • Position yourself as an industry leader
  • Increase your brand recognition
  • Create new partnerships and alliances
  • Showcase products and services to a targeted audience of decision-makers 
 
Target your market!
 
For details contact Gaurav Koul or call +44 (0)20 7092 1233

Get sponsor pack

The ViE Awards 2009
 
Nominations are open!
The ViE Awards are more than just a trophy -  they are a recognition of the vaccine industry’s achievements and contributions to the forward development of the immunotherapy industry. 
Categories include:
  • Best therapeutic vaccine
  • Best prophylactic vaccine
  • Best vaccine partnership alliance
  • Best vaccine R&D pipeline
  • Best biotech start-up
  • Pharma vaccine executive of the year
  • Biotech CEO of the year
  • Best contract research organisation
  • Best contract manufacturing organisation